Toxic epidermal necrolysis: Revisiting the tentative link between early apoptosis and late necrosis (Review)

International Journal of Molecular Medicine

Volumn 19, Issue 1, 2007, Pages 3-10

  Paquet, Philippe ^a   Pierard, Gerald E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Apoptosis; Necrosis; Toxic epidermal necrolysis

Indexed keywords

APOPTOSIS; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; HUMAN; KERATINOCYTE; METABOLISM; MITOCHONDRION; NECROSIS; OXIDATION REDUCTION REACTION; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TOXIC EPIDERMAL NECROLYSIS;

APOPTOSIS; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; KERATINOCYTES; MITOCHONDRIA; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; NECROSIS; OXIDATION-REDUCTION; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 39049179425     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.1.3     Document Type: Review

References (47)

1. Fritsch PO and Sidoroff A: Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol 1: 349-360, 2000.
2. Roujeau JC, Kelly JP, Naldi L, et al: Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333: 1600-1607, 1995.
3. Paul C, Wolkenstein P, Adle H, Wechsler J, Garchon HJ, Revuz J and Roujeau JC: Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 134: 710-714, 1996. (Pubitemid 26120740)
4. Baron JM and Merk HF: Drug metabolism in the skin. Curr Opin Allergy Clin Immunol 1: 287-291, 2001.
5. Wolkenstein P, Tan C, Lecoeur S, et al: Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin. Chem Biol Interact 113: 39-50, 1998. (Pubitemid 28279790)
6. Rzany B, Hering O, Mockenhaupt M, Schröder W, Goerttler E, Ring J and Schöpf E: Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 135: 6-11, 1996. (Pubitemid 26225106)
7. Paquet P, Nikkels A, Arrese JE, Vanderkelen A and Piérard GE: Macrophages and tumor necrosis factor-alpha in toxic epidermal necrolysis. Arch Dermatol 130: 605-608, 1994. (Pubitemid 24150940)
8. Viard I, Wehrli P, Bullani R, et al: Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282: 490-493, 1998. (Pubitemid 28483679)
9. Paquet P and Piérard GE: Epidermal calprotectin in druginduced toxic epidermal necrolysis. J Cutan Pathol 26: 301-305, 1999. (Pubitemid 29373928)
10. Paquet P, Jacob E, Pirson J and Piérard GE: Drug-induced toxic epidermal necrolysis and pancytopenia: A puzzling association. Int J Mol Med 16: 29-33, 2005.
11. Hetts S: To die or not to die: An overview of apoptosis and its role in disease. JAMA 279: 300-307, 1998.
12. Hung RWY and Chow AW: Dissecting the 'end game': clinical relevance, molecular mechanisms and laboratory assessment of apoptosis. Clin Invest Med 27: 324-344, 2004.
13. Morishima N, Nakanishi K, Takenacchi H, Shibata T and Yasuhiko Y: An endoplasmic reticulum stress-specific caspase cascade in apoptosis. J Biol Chem 277: 34287-34294, 2002.
14. Rao RV, Castro-Obregon S, Frankowski H, et al: Coupling endoplasmic reticulum stress to the cell death program. J Biol Chem 277: 21836-21842, 2002.
15. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
16. Reed JC: Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol 11: 68-75, 1999.
17. Shear N, Spielberg S, Grant D, Tang BK and Kalow W: Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Int Med 105: 179-184, 1986. (Pubitemid 16039289)
18. Cribb AG, Miller M, Leeder JS, Hill J and Spielberg SP: Reaction of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Drug Metab Dispos 19: 900-906, 1991.
19. Cribb AE, Nakamura H, Grant DM, Miller MA and Spielberg SP: Role of the polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulfamethoxazole metabolism. Biochem Pharmacol 45: 1277-1282, 1993. (Pubitemid 23098325)
20. Grant DM, Blum M, Beer M and Meyer UA: Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 39: 184-191, 1991.
21. Reilly T, Lash LH, Doll MA, Hein DW, Woster PM and Svensson CK: A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol 114: 1164-1173, 2000. (Pubitemid 30415234)
22. Dietrich A, Kawakubo Y, Rzany B, Mockenhaupt M, Simon JC and Schöpf E: Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Exp Dermatol 4: 313-316, 1995.
23. Herzenberg LA, Rosa SCD and Dubs JE: Glutathione deficiency is associated with compound survival in HIV diseases. Proc Natl Acad Sci USA 94: 1967-1972, 1997.
24. Staal FJT, Ela SW, Rodenrer M, Anderson MT and Herzenberg LA: Glutathione deficiency and human immunodeficiency virus infection. Lancet 339: 909-912, 1992.
25. Saiag P, Caumes E, Chosidow O, Revuz J and Roujeau JC: Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 26: 567-574, 1992.
26. Hess D, Sisson M, Suria H, Wijsman J, Puvanesasungham R, Madrenas J and Rieders MJ: Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8+ cells by the hydroxylamine of sulfamethoxazole. FASEB J 13: 1688-1698, 1999. (Pubitemid 29473331)
27. Naisbitt DJ, Williams DP, Pirmohamed M, Kitteringham NR and Park BK: Reactive metabolites and their role in drug reactions. Curr Opin Allergy Clin Immunol 1: 317-325, 2001.
28. Shapiron LE and Shear NH: Mechanisms of drug reactions: the metabolic track. Semin Cutan Med Surg 15: 217-227, 1996. (Pubitemid 27197960)
29. Schreck R and Bauerle P: A role for oxygen radicals as second messengers. Trends Cell Biol 1: 39-42, 1991. (Pubitemid 121002486)
30. Schreck R, Albermann KAJ and Baeuerle P: Nuclear factor κß: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Comm 17: 221-237, 1992.
31. Safarian T and Bredesen D: Is apoptosis mediated by reactive oxygen species? Free Radic Res 21: 1-8, 1994.
32. Lange RW, Hayden PJ, Chignell CF and Luster MI: Anthralin stimulates keratinocyte-derived proinflammatory cytokines via generation of reactive oxygen species. Inflamm Res 47: 174-181, 1998.
33. Paquet P and Piérard GE: Soluble fractions of tumor necrosis factor-α, interleukin 6 and of their receptors in toxic epidermal necrolysis: A comparison with second-degree burns. Int J Mol Med 1: 459-462, 1998.
34. Correia O, Delgado L, Leal Barbosa I, Campilho F and Fleming-Torrinha J: Increased interleukin 10, tumor necrosis factor α, and interleukin 6 level in blister fluid of toxic epidermal necrolysis. J Am Acad Dermatol 47: 58-62, 2002.
35. Moncada S, Palmer RJ and Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-116, 1991.
36. Lerner LH, Qureshi AA, Reddy BV and Lerner EA: Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome. J Invest Dermatol 114: 196-199, 2000. (Pubitemid 30195995)
37. Ettore A, Andreassi M, Anselmi C, Neri P, Andreassi L and Di Stefano A: Involvement of oxidative stress in apoptosis induced by a mixture of isothiazolinones in normal human keratinocytes. J Invest Dermatol 121: 328-336, 2003. (Pubitemid 36969907)
38. Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H and Shimizu H: Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 162: 1515-1520, 2003. (Pubitemid 36512833)
39. Arnold R, Seifert M, Asadullah K and Volk HD: Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. J Immunol 162: 7140-7147, 1999. (Pubitemid 29277684)
40. Halliwell B: Free radicals and antioxidants: a personal view. Nutr Rev 52: 253-265, 1994.
41. Bruch-Gerharz D, Ruzicka T and Kolb-Bachofen V: Nitric oxide in human skin: current status and future prospects. J Invest Dermatol 110: 1-7, 1998. (Pubitemid 28086054)
42. Kröncke KD, Fehsel K and Kolb-Bachofen V: Nitric oxide: cytotoxicity versus cytoprotection - how, why, when, and where? Nitric Oxide Biol Chem 1: 107-120, 1997.
43. Melino G and Bernassola F: S-nitrosylation regulates apoptosis. Nature 388: 432-433, 1997.
44. Garcia-Doval I, Le Cleach L, Bocquet H, Otero XL and Roujeau JC: Toxic epidermal necrolysis and Stevens-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 136: 323-327, 2000.
45. Redondo P, De Felipe I, De la Pena A, Azamendra JM and Vanaclocha U: Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis treatment with N-acetylcysteine. Br J Dermatol 136: 633-634, 1997.
46. Velez A and Moreno JC: Toxic epidermal necrolysis treated with N-acetylcysteine. J Am Acad Dermatol 46: 469-470, 2002. (Pubitemid 34225424)
47. Paquet P, Piérard GE and Quatresooz P: Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome). Int Arch Allergy Immunol 136: 205-216, 2005. (Pubitemid 40529192)